Q2 STOCKS TO BUY

TG Therapeutics Stock Plummets After FDA Update

The stock is trading at new annual lows

Deputy Editor
Nov 30, 2021 at 10:23 AM
facebook X logo linkedin


TG Therapeutics Inc (NASDAQ:TGTX) stock is plummeting today, down 45.4% to trade at $12.75 at last check. The company is struggling to secure a date with the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) to review its application for its combination cancer drug "U2" (ublituximab and umbralisib). TG Therapeutics added that they believe the meeting will happen in March or April of 2022, though the target date was much earlier.

Today's bear gap has TGTX trading at fresh annual lows, down 73.8% year-to-date. Plus, the 320-day moving average has kept a tight lid on breakouts since early August. It's also worth noting, however, that the stock's Relative Strength Index (RSI) of 13 sits firmly in "oversold" territory, which typically predates a short-term bounce. 

There is ample room for downgrades amongst the brokerage bunch, unless they choose to wait it out. All six analysts in coverage carry a "strong buy" rating on TG Therapeutics stock. Plus, the 12-month consensus price target of $58.38 is an over 300% premium to current levels. 

Meanwhile, short interest makes up 10.2% of TGTX's available float. In other words, it would take over 11 days to buy back these bearish bets, at the stock's average pace of trading -- leaving plenty of potential for a short squeeze. Due to the volatile price action, though, the equity has landed on the Short Sale Restricted (SSR) list today. 

The stock's typically quiet options pits are bustling with activity this morning, with options volume running at five times what's typically seen. The December 15 call is the most popular, with new positions being opened at the contract. 

 

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter